Tumor cell interactions with the extracellular matrix during invasion and metastasis.
暂无分享,去创建一个
L. Liotta | W. Stetler-Stevenson | L A Liotta | S Aznavoorian | W G Stetler-Stevenson | S. Aznavoorian
[1] D. Miles,et al. Activity of type IV collagenases in benign and malignant breast disease. , 1993, British Journal of Cancer.
[2] S. Ménard,et al. Prognostic significance of the 67-kilodalton laminin receptor expression in human breast carcinomas. , 1993, Journal of the National Cancer Institute.
[3] T M Grogan,et al. Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice. , 1993, Cancer research.
[4] U. Moll,et al. Mr 92,000 Type IV Collagenase Is Increased in Plasma of Patients with Colon Cancer and Breast Cancer , 1993 .
[5] Y. Sasaguri,et al. Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma. A clinicopathologic study. , 1993, American journal of clinical pathology.
[6] Catherine,et al. Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas. , 1993, Cancer research.
[7] P. Chambon,et al. Breast-cancer-associated stromelysin-3 gene is expressed in basal cell carcinoma and during cutaneous wound healing. , 1992, The Journal of investigative dermatology.
[8] L. Liotta,et al. Linkage analysis demonstrates that the Timp-2 locus is on mouse chromosome 11. , 1992, Genomics.
[9] Kerbel Rs. Expression of multi-cytokine resistance and multi-growth factor independence in advanced stage metastatic cancer. Malignant melanoma as a paradigm. , 1992 .
[10] L. Liotta,et al. Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions. , 1992, The Journal of biological chemistry.
[11] R Poulsom,et al. Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia. , 1992, The American journal of pathology.
[12] C. Dinney,et al. Metastatic model for human prostate cancer using orthotopic implantation in nude mice. , 1992, Journal of the National Cancer Institute.
[13] L. Liotta,et al. Evaluation of Basement Membrane Components and the 72 kDa Type IV Collagenase in Serous Tumors of the Ovary , 1992, The American journal of surgical pathology.
[14] M. Cockett,et al. The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases. , 1992, The Biochemical journal.
[15] M. Hendrix,et al. Role of the alpha v beta 3 integrin in human melanoma cell invasion. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[16] T. Hurskainen,et al. Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. , 1992, Cancer research.
[17] W. Stetler-Stevenson,et al. Higher-order complex formation between the 72-kilodalton type IV collagenase and tissue inhibitor of metalloproteinases-2. , 1992, Biochemistry.
[18] I. Hart,et al. Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44. , 1991, Cancer research.
[19] L. Liotta,et al. Comparison of autocrine mechanisms promoting motility in two metastatic cell lines: Human melanoma and ras‐transfected NIH3T3 cells , 1991, International journal of cancer.
[20] D. Powe,et al. Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours , 1991, International journal of cancer.
[21] E. Howard,et al. Binding of tissue inhibitor of metalloproteinases 2 to two distinct sites on human 72-kDa gelatinase. Identification of a stabilization site. , 1991, The Journal of biological chemistry.
[22] K. Suzuki,et al. Substrate specificities and activation mechanisms of matrix metalloproteinases. , 1991, Biochemical Society transactions.
[23] Kenneth M. Yamada,et al. Adhesive recognition sequences. , 1991, The Journal of biological chemistry.
[24] W. Fiers,et al. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role , 1991, Cell.
[25] L. Liotta,et al. Laminin receptors, collagenase IV and prognosis in node‐negative breast cancers , 1991, International journal of cancer.
[26] L. Liotta,et al. Tumor cell invasion inhibited by TIMP-2. , 1991, Journal of the National Cancer Institute.
[27] H. Shimada,et al. Inhibition of tumor invasion of smooth muscle cell layers by recombinant human metalloproteinase inhibitor. , 1991, Cancer research.
[28] J. Thiery,et al. Secreted or nonsecreted forms of acidic fibroblast growth factor produced by transfected epithelial cells influence cell morphology, motility, and invasive potential. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[29] H. Birkedal‐Hansen,et al. Characteristics of a 95-kDa matrix metalloproteinase produced by mammary carcinoma cells. , 1991, Biochemistry.
[30] L. Matrisian,et al. Expression and localization of the matrix metalloproteinase pump‐1 (MMP‐7) in human gastric and colon carcinomas , 1991, Molecular carcinogenesis.
[31] T. Hamilton,et al. Effects of synthetic peptides and protease inhibitors on the interaction of a human ovarian cancer cell line (NIH:OVCAR-3) with a reconstituted basement membrane (Matrigel). , 1991, Invasion & metastasis.
[32] H. Yamamoto,et al. Motility factor produced by malignant glioma cells: role in tumor invasion. , 1990, Journal of neurosurgery.
[33] A Yasui,et al. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. , 1990, European journal of biochemistry.
[34] J Vandekerckhove,et al. Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells , 1990, The Journal of cell biology.
[35] L. Liotta,et al. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. , 1990, The Journal of biological chemistry.
[36] L. Orci,et al. Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene , 1990, Cell.
[37] C. Meijer,et al. Adhesion molecules in the prognosis of diffuse large-cell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a/18), and ICAM-1 (CD54). , 1990, Leukemia.
[38] I. Stamenkovic,et al. CD44 is the principal cell surface receptor for hyaluronate , 1990, Cell.
[39] T. Wobbes,et al. Correlation between collagenolytic activity and grade of histological differentiation in colorectal tumors , 1990, International journal of cancer.
[40] B. Vogelstein,et al. A genetic model for colorectal tumorigenesis , 1990, Cell.
[41] M. Elices,et al. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/Fibronectin binding site , 1990, Cell.
[42] R. Kerbel. Growth dominance of the metastatic cancer cell: cellular and molecular aspects. , 1990, Advances in cancer research.
[43] L. Liotta,et al. The type I insulin-like growth factor receptor is a motility receptor in human melanoma cells. , 1989, The Journal of biological chemistry.
[44] R. Tizard,et al. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes , 1989, Cell.
[45] A. Eisen,et al. Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[46] W. Birchmeier,et al. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion , 1989, The Journal of cell biology.
[47] P. Waterhouse,et al. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. , 1989, Science.
[48] E. Kohn,et al. Insulin-like growth factors stimulate chemotaxis in human melanoma cells. , 1988, Biochemical and biophysical research communications.
[49] H. Willard,et al. A primary genetic map of the pericentromeric region of the human X chromosome. , 1988, Genomics.
[50] M. Humphries,et al. Investigation of the biological effects of anti-cell adhesive synthetic peptides that inhibit experimental metastasis of B16-F10 murine melanoma cells. , 1988, The Journal of clinical investigation.
[51] Brenda Kahan,et al. Nerve growth factor stimulation of mouse embryonal carcinoma cell migration. , 1987, Cancer research.
[52] L. Liotta,et al. Role of laminin receptor in tumor cell migration. , 1987, Cancer research.
[53] L. Liotta,et al. Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domains , 1987, The Journal of cell biology.
[54] E Ruoslahti,et al. New perspectives in cell adhesion: RGD and integrins. , 1987, Science.
[55] E. Roos,et al. Inhibition of lymphoma invasion and liver metastasis formation by pertussis toxin. , 1987, Cancer research.
[56] L. Liotta,et al. Cytokine-induced pseudopodial protrusion is coupled to tumour cell migration , 1987, Nature.
[57] G. Nicolson,et al. Chemotactic response of rat mammary adenocarcinoma cell clones to tumor-derived cytokines. , 1987, Biochemical and biophysical research communications.
[58] L. Liotta,et al. Pertussis toxin inhibits stimulated motility independently of the adenylate cyclase pathway in human melanoma cells. , 1987, Biochemical and biophysical research communications.
[59] L. Liotta,et al. Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a. , 1987, Cancer research.
[60] D. Rifkin,et al. Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade , 1986, Cell.
[61] L. Liotta,et al. Altered levels of laminin receptor mRNA in various human carcinoma cells that have different abilities to bind laminin. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[62] L. Liotta,et al. Tumor cell autocrine motility factor. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[63] R. Thompson,et al. Primary structure and cDNA cloning of human fibroblast collagenase inhibitor. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[64] R. Daynes,et al. Inhibition of lymphocyte and neutrophil chemotaxis by pertussis toxin. , 1985, Journal of immunology.
[65] H. Bourne,et al. Pertussis toxin inhibition of chemotactic factor-induced calcium mobilization and function in human polymorphonuclear leukocytes , 1985, The Journal of experimental medicine.
[66] H. Welgus,et al. Human skin fibroblast collagenase inhibitor. Comparative studies in human connective tissues, serum, and amniotic fluid. , 1983, The Journal of biological chemistry.
[67] J. Reynolds,et al. Purification of rabbit bone inhibitor of collagenase. , 1981, The Biochemical journal.
[68] D. R. Coman. Mechanisms responsible for the origin and distribution of blood-borne tumor metastases: a review. , 1953, Cancer research.